1. Home
  2. AGIO vs CHEF Comparison

AGIO vs CHEF Comparison

Compare AGIO & CHEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • CHEF
  • Stock Information
  • Founded
  • AGIO 2007
  • CHEF 1985
  • Country
  • AGIO United States
  • CHEF United States
  • Employees
  • AGIO N/A
  • CHEF N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • CHEF Food Distributors
  • Sector
  • AGIO Health Care
  • CHEF Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • CHEF Nasdaq
  • Market Cap
  • AGIO 2.4B
  • CHEF 2.6B
  • IPO Year
  • AGIO 2013
  • CHEF 2011
  • Fundamental
  • Price
  • AGIO $40.72
  • CHEF $55.56
  • Analyst Decision
  • AGIO Strong Buy
  • CHEF Strong Buy
  • Analyst Count
  • AGIO 5
  • CHEF 7
  • Target Price
  • AGIO $57.25
  • CHEF $68.86
  • AVG Volume (30 Days)
  • AGIO 577.5K
  • CHEF 535.0K
  • Earning Date
  • AGIO 10-30-2025
  • CHEF 10-29-2025
  • Dividend Yield
  • AGIO N/A
  • CHEF N/A
  • EPS Growth
  • AGIO N/A
  • CHEF 63.82
  • EPS
  • AGIO 11.13
  • CHEF 1.62
  • Revenue
  • AGIO $40,875,000.00
  • CHEF $3,950,674,000.00
  • Revenue This Year
  • AGIO $23.76
  • CHEF $9.06
  • Revenue Next Year
  • AGIO $148.23
  • CHEF $7.54
  • P/E Ratio
  • AGIO $3.67
  • CHEF $34.17
  • Revenue Growth
  • AGIO 30.57
  • CHEF 7.90
  • 52 Week Low
  • AGIO $23.42
  • CHEF $38.36
  • 52 Week High
  • AGIO $62.58
  • CHEF $68.94
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 63.66
  • CHEF 35.31
  • Support Level
  • AGIO $39.32
  • CHEF $53.28
  • Resistance Level
  • AGIO $41.42
  • CHEF $55.80
  • Average True Range (ATR)
  • AGIO 1.34
  • CHEF 2.05
  • MACD
  • AGIO 0.34
  • CHEF -0.71
  • Stochastic Oscillator
  • AGIO 87.58
  • CHEF 14.33

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.

Share on Social Networks: